GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

GLAUKOS Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$166.96+2.12 (+1.29%)

Close on Oct 19, 2026

Market cap: $9.82B
P/E (TTM): –
Dividend yield: –

GLAUKOS Corp income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Revenue	507	383	315	283	294	225	237	181	159	114	72	46	21
Cost of Revenue	112	94	76	69	67	92	39	25	21	16	13	11	2.54
Gross Profit	283	289	239	214	227	133	198	156	138	98	59	34	18
Research & Development	151	136	139	123	101	85	68	50	39	29	25	19	16
Selling, General & Admin	332	261	224	193	179	171	177	120	96	65	44	28	17
Advertising Expenses	4.30	3.60	3.40	2.50	1.20	1.60	2.50	1.80	2.10	1.60	0.80	0.40	0.50
Operating Expenses	482	412	368	296	260	257	249	169	140	94	69	47	33
Operating Income	-200	-122	-129	-82	-33	-124	-50	-13	-2.28	4.24	-10	-13	-14
Interest Expense	4.64	10	14	14	13	14	2.57	–	–	–	–	–	–
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	0.08	0.00	0.01
Other Non-Operating Income	6.56	-23	-5.03	-16	-16	-8.76	0.26	0.63	2.28	0.32	-28	-0.87	-0.02
Merger & Restructuring Charges	–	–	–	–	–	–	4.12	–	–	–	–	–	–
Asset Impairment Charges	0	0	0	0	0	0	0.40	0	0	0	0	–	–
Gain (Loss) on Sale of Assets	-0.03	-0.60	-0.89	0.02	-0.01	-0.37	-0.43	-0.16	-0.01	-0.04	–	–	–
Legal Settlements	–	–	–	30	30	–	–	–	–	–	–	–	–
Pretax Income	-193	-146	-134	-98	-49	-132	-50	-12	0.00	4.57	-38	-14	-14
Income Tax Expense	-5.35	0.77	0.93	0.77	0.33	-12	-65	0.58	0.09	0.04	0.03	0.02	0.01
Net Income incl. Noncontrolling Interests	-188	-146	-135	-99	-50	-120	15	-13	-0.09	4.52	-38	-14	-14
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	–	-1.08	-1.93	-1.59
Net Income	-188	-146	-135	-99	-50	-120	15	-13	-0.09	4.52	-37	-12	-13
EPS (Basic)(per share)	-3.28	-2.77	-2.78	-2.09	-1.07	-2.70	0.41	-0.37	0.00	0.14	-2.13	-5.29	-6.21
EPS (Diluted)(per share)	-3.28	-2.77	-2.78	-2.09	-1.07	-2.70	0.37	-0.37	0.00	0.12	-2.13	-5.29	-6.21
Shares Outstanding (Basic, Weighted)(shares)	57	53	48	47	46	44	37	35	34	33	17	2.29	2.04
Shares Outstanding (Diluted, Weighted)(shares)	57	53	48	47	46	44	41	35	34	36	17	2.29	2.04
EBITDA	-162	-87	-95	-51	-3.21	-94	-44	-6.74	3.20	8.96	-6.03	-8.94	-13

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 60.7%
Operating margin: -31.6%
Net margin: -30.7%
Return on equity, FY2025: -26.4%

Financial strength

Current ratio: 5.04
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 111.9%

Valuation

P/E ratio: –
Price to sales: 16.02
Price to book: 14.39
Dividend yield: –